Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1910
+0.0061 (3.30%)
At close: Apr 2, 2025, 4:00 PM
0.1959
+0.0049 (2.57%)
After-hours: Apr 2, 2025, 7:28 PM EDT

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
10151017217-
Upgrade
Market Cap Growth
55.53%55.53%-41.17%-92.39%--
Upgrade
Enterprise Value
949456196-
Upgrade
Last Close Price
0.180.291.793.2283.40-
Upgrade
PS Ratio
4.3425.95142.82---
Upgrade
PB Ratio
5.598.884.351.368.51-
Upgrade
P/TBV Ratio
--51.661.649.25-
Upgrade
EV/Sales Ratio
14.7583.40658.24---
Upgrade
Debt / Equity Ratio
0.400.4018.740.100.110.38
Upgrade
Asset Turnover
0.020.020.00---
Upgrade
Quick Ratio
0.740.741.221.624.810.52
Upgrade
Current Ratio
0.800.801.461.795.100.55
Upgrade
Return on Equity (ROE)
-2264.31%-2264.31%-302.20%-130.70%-739.07%-83.79%
Upgrade
Return on Assets (ROA)
-39.64%-39.64%-36.19%-63.25%-77.17%-32.34%
Upgrade
Return on Capital (ROIC)
-46.41%-46.41%-45.05%-81.98%-88.41%-43.53%
Upgrade
Earnings Yield
-462.73%-294.88%-223.12%-148.88%-56.47%-
Upgrade
FCF Yield
-168.30%-107.29%-210.34%-128.86%-10.89%-
Upgrade
Buyback Yield / Dilution
-156.81%-156.81%-74.17%-40.92%-146.19%-
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q